[65 Pages Report] The global medical decision support systems for sepsis market is projected to reach USD 35.6 Million by 2022 from USD 12.0 Million in 2017, at a CAGR of 24.3%. Increasing funding and research grants, growing pressure to curb healthcare spending, and improving patient outcomes are driving the growth of this market.

Objectives of the Study:

To define, describe, and forecast the global medical decision support systems for sepsis market on the basis of region

To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)

To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market

To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World

To strategically analyze the market structure and profile the key players of global clinical decision support systems and comprehensively analyze their core competencies

To track and analyze competitive developments such as agreements, collaborations, and partnerships; product launches, enhancements, & integrations; and acquisitions in the CDSS market

Research Methodology:

Top-down and bottom-up approaches were used to estimate and validate the size of the global market in the overall medical decision support systems for sepsis market.

Various secondary sources such as associations like Healthcare Information and Management Systems Society (HIMSS), American Medical Informatics Association (AMIA), Global Sepsis Alliance, Surviving Sepsis Campaign (SSC), Agency for Healthcare Research and Quality (AHRQ), American Association of Healthcare Administrative Management (AAHAM), American Journal of Medicine, Journal of the American Medical Association (JAMA), Organisation for Economic Co-operation and Development (OECD), World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Institute for Health Technology Transformation (iHT2), American Medical Group Association (AMGA), The LANCET Infectious Diseases, International Association of Health Policy (IAHP), UK Sepsis Trust, National Health Services (NHS), Institute of Population and Public Health (IPPH), European Federation for Medical Informatics (EFMI), Australian Sepsis Network, Expert Interviews, Investor Presentations, SEC Filings, Company Annual Reports, and MarketsandMarkets Analysis have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

This research report provides information on the history of sepsis management modules, various players operating in this market and the description of their unique product offerings. The report provides a global and regional perspective of the sepsis decision support and categorizes the global market into the following segments:

Medical decision support systems for sepsis market, by Region

North America

Europe

Asia Pacific

Rest of the World (RoW)

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Portfolio Assessment

Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies in the market

The global medical decision support systems for sepsis market is projected to reach USD 35.6 Million by 2022 from an estimated USD 12.0 Million in 2017, at a CAGR of 24.3%. This growth can be attributed to factors such as increasing funding and research grants, growing pressure to curb healthcare spending, and improving patient outcomes are driving the growth of this market.

Geographically, the North American market accounted for the largest share in 2017 and is expected to register the highest CAGR during the forecast period. The large share and high growth can be attributed to factors such as increasing efforts to curb healthcare spending, federal initiatives such as the Hospital Readmissions Reduction Program, and rising investments in HCIT solutions in the country. Major players providing sepsis CDS modules include Cerner, Epic, and MEDITECH. Third-party vendors like VigiLanz, Iatric Systems, and PeraHealth are also based out of the US. The presence of these key players in the country has made the US a center of innovation in the CDSS market. Moreover, growing awareness regarding the use of HCIT solutions for sepsis management, high number of installations of CDS solutions, and various studies have been conducted to check benchmark for the efficacy of different solutions in the US.

Europe accounted for second largest share of the market and followed by Asia Pacific in 2017. The large share of the European global medical decision support systems for sepsis market can be attributed to the increasing initiative by government to prevent avoidable cases of sepsis and spread sepsis awareness. For instance, in March 2018, under the patronage of the EU Commissioner for Health and Food Safety, more than 40 European member organizations gathered under the Global Sepsis Alliance. The Alliance aimed at encouraging all European countries to develop national Action Plans and strategies to improve prevention, recognition, management, and rehabilitation of sepsis; promote sepsis awareness; and encourage and support the European Center for Disease Control (ECDC) to engage in sepsis education for citizens and healthcare professionals.